This Sources Sought opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
(RFI): Validation of Emerging Defense & Detection Equipment for Readiness (VEDDER) Prototype Accelerator
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The United States, through the Department of Defense and the Portfolio Acquisition Executive-Layered Protection & Integration, is pursuing an unprecedented public-private innovation model to counter the strategic technological threat posed by the People’s Republic of China, particularly through its Military-Civil Fusion strategy. This effort is embodied in the Validation of Emerging Defense & Detection Equipment for Readiness (VEDDER) Prototype Accelerator, an Other Transaction Authority (OTA) initiative governed by 10 U.S.C. § 4022 and Section 236 of Public Law 118-159, designed to bypass traditional seven-to-fifteen-year acquisition timelines that fail to keep pace with advancements in biotechnology and artificial intelligence. The program will be executed through a 501(c)(3) non-profit partner that will act as a dynamic, continuously operating accelerator, independently scouting and contracting with commercial entities—including biotechnology startups, AI developers, and non-traditional vendors—using a system-of-systems framework to rapidly prototype medical countermeasures. The Government will provide funding via a master OTA, enabling the NFP to implement commercial-style sub-agreements that shield innovators from burdensome FAR/DFARS accounting requirements while ensuring stringent alignment with national security objectives. Core deliverables include the establishment of an operational hub, quarterly scouting reports, executed B2B prototyping agreements, a high-performance computing integration plan leveraging LLNL or equivalent resources for in silico testing, and final prototype demonstration reports for AI-driven medical countermeasures. The program enforces strict domestic manufacturing safeguards through mandatory march-in rights if any partner offshores production or sells exclusive rights to a strategic competitor, alongside comprehensive flowdown clauses that protect U.S. government interests, data rights, and supply chain integrity. Intellectual property arrangements adopt commercial-style mechanisms to preserve private-sector viability while guaranteeing government access to critical technologies. All software and systems must comply with Executive Order 14028, NIST SP 800-218, DoD RMF (DoDI 8510.01 and 8500.01), NIST SP 800-53 Rev 5, and DISA STIGs/SRGs, with mandatory Software Bill of Materials submission and DAST/SAST testing. CUI and mission-critical data must be protected under DoD Impact Level 5 protocols, with all infrastructure, data residency, and personnel access restricted to the Continental United States and U.S. citizens only, using
General Info
Agency
NAICS
Place of Performance
Aberdeen Proving Ground, MD, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The United States and the Portfolio Acquisition Executive-Layered Protection &Integration (PAE-LPI) is engaged in a critical, persistent innovation race against strategic competitors, most notably the People's Republic of China (PRC), which leverages Military-Civil Fusion to mandate the immediate transfer of commercial breakthroughs to military applications. Traditional Department of War (DoW) acquisition models operating on 7-to-15-year timelines are structurally incapable of pacing the threat in rapidly evolving domains like biotechnology and artificial intelligence (AI).
To maintain technological overmatch and secure the United States’ biotechnology ecosystem (projected to exceed $1.5 trillion), the Government requires an asymmetric response that harnesses the dynamic, free-market ecosystem of private capital, academia, and commercial enterprise. Drawing inspiration from venture-backed intelligence community models, this Other Transaction Agreement (OTA) establishes a public-private nexus.
The objective of this OTA is to establish a technology accelerator with a 501(c)(3) partner. Supported by Government investment, this accelerator will speed the prototyping of new technologies; specifically medical countermeasures (MCMs), by bridging the private sector, elite national High-Performance Computing (HPC) resources, and the Government.
More opportunities from Department Of Defense → W6QK Acc-Apg
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
